In order to explore a suitable dose of tunicamycin for treatment of tumor in vivo, we determined the antitumor activity of tunicamycin alone in nude mice bearing SKBR3 and MCF-7/HER2 cancer cells xenografts, respectively. This evidence concerns the gene ERBB2 and cancer.